ArcherDX Announces Close of $60M Financing to Advance Companion Diagnostic and Minimal Residual Disease Monitoring Product Portfolio May 15, 2019
ArcherDX announces collaboration with University College London to Investigate the Novel Use of Cell-Free Tumor DNA to Detect Disease Recurrence in Lung Cancer Patients March 28, 2019
ArcherDX Announces Expansion of Executive Leadership Team as Company Continues to Experience Rapid Growth March 5, 2019
